| Income Statement |
| Total Revenue | 95.59M |
|
| Revenues (USD) | 95.59M |
| Cost of Revenue | 24.07M |
| Gross Profit | 71.52M |
| Operating Expenses | 59.26M |
| Research and Development Expense | 3.66M |
| Selling, General and Administrative Expense | 55.60M |
| Operating Income | 12.26M |
| Income Tax Expense | 2.63M |
| Net Income | 17.06M |
| Net Income Common Stock | 17.06M |
| Net Income Common Stock (USD) | 17.06M |
| Consolidated Income | 17.06M |
| Earnings per Basic Share | 0.29 |
| Earnings per Basic Share (USD) | 0.29 |
| Earnings per Diluted Share | 0.29 |
| Earning Before Interest & Taxes (EBIT) | 19.69M |
| Earning Before Interest & Taxes (USD) | 19.69M |
| Weighted Average Shares | 58.90M |
| Weighted Average Shares Diluted | 59.38M |
| Balance Sheet |
| Cash and Equivalents | 396.17M |
| Cash and Equivalents (USD) | 396.17M |
| Investments | 105.64M |
| Investments Current | 104.94M |
| Investments Non-Current | 700.00K |
| Trade and Non-Trade Receivables | 50.24M |
| Current Assets | 650.00M |
| Property, Plant & Equipment Net | 11.32M |
| Total Assets | 720.33M |
| Total Debt | 4.45M |
| Current Liabilities | 79.44M |
| Debt Non-Current | 4.45M |
| Total Liabilities | 91.20M |
| Shareholders Equity | 629.13M |
| Shareholders Equity (USD) | 629.13M |
| Assets Non-Current | 70.34M |
| Total Debt (USD) | 4.45M |
| Deferred Revenue | 17.94M |
| Inventory | 71.66M |
| Liabilities Non-Current | 11.76M |
| Trade and Non-Trade Payables | 18.79M |
| Tax Assets | 52.63M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 179.00K |
| Net Cash Flow from Financing | -56.49M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.88M |
| Capital Expenditure | -211.00K |
| Issuance (Purchase) of Equity Shares | -56.51M |
| Net Cash Flow from Investing | 37.68M |
| Net Cash Flow - Investment Acquisitions and Disposals | 37.90M |
| Net Cash Flow from Operations | 21.05M |
| Effect of Exchange Rate Changes on Cash | -365.00K |
| Share Based Compensation | 3.71M |